| Newsroom
The Media section provides reporters with easy access to Genentech information for stories in development. It also houses our recent and archived press releases.
Arbitration Panel Decision Received in Decision-Making
Disagreement Between Genentech and Biogen Idec
Recent Press Releases
Jul 2, 2009 Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion May 30, 2009 Genentech Announces Full Results from First Phase III Study of Avastin in Early-Stage Colon Cancer May 30, 2009 Phase III Study Showed Patients Lived Longer Without Advanced Lung Cancer Progressing When Tarceva Was Added to Avastin as First-Line Maintenance Therapy May 29, 2009 Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival in Advanced Breast Cancer  |
|
Media
|
|
